If all is good, then why do we need new options? Yes, HIV treatment – daily oral regimen – is lifesaving and good – access to ...

If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in ...

The long-acting injectable drug for PrEP, cabotegravir, sold under the brand name Apretude, was approved by Health Canada in 2024 to reduce the risk of sexually acquired HIV. The antiretroviral ...

Lamivudine oral tablet is a generic prescription drug used to treat HIV alongside other antiretroviral drugs, and to treat long-term hepatitis B. It’s usually taken once or twice per day.

Many treatments can help people with HIV live longer, more fulfilling lives. The main treatment for HIV is antiretroviral medication. Every year, researchers are investigating new therapies in the ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

A modeling study looked at how anticipated cuts to international HIV funding would affect the rate of new cases and ...

The HIV Drugs Market is expected to grow steadily from 2025 to 2035, driven by advancements in antiretroviral therapy and increasing global awareness initiatives. Rising HIV prevalence, improved ...

This story is part of CBC Health's Second Opinion, a weekly analysis of health and medical science news emailed to subscribers on Saturday mornings. If you haven't subscribed yet, you can do that ...